Annual CFF
$16.39 M
-$63.55 M-79.50%
December 31, 2023
Summary
- As of February 12, 2025, PLSE annual cash flow from financing activities is $16.39 million, with the most recent change of -$63.55 million (-79.50%) on December 31, 2023.
- During the last 3 years, PLSE annual CFF has fallen by -$14.50 million (-46.94%).
- PLSE annual CFF is now -79.50% below its all-time high of $79.94 million, reached on December 31, 2022.
Performance
PLSE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$61.90 M
+$62.16 M+23458.11%
September 30, 2024
Summary
- As of February 12, 2025, PLSE quarterly cash flow from financing activities is $61.90 million, with the most recent change of +$62.16 million (+23458.11%) on September 30, 2024.
- Over the past year, PLSE quarterly CFF has increased by +$61.59 million (+20194.75%).
- PLSE quarterly CFF is now -4.86% below its all-time high of $65.06 million, reached on September 30, 2022.
Performance
PLSE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$62.74 M
+$59.75 M+1996.32%
September 30, 2024
Summary
- As of February 12, 2025, PLSE TTM cash flow from financing activities is $62.74 million, with the most recent change of +$59.75 million (+1996.32%) on September 30, 2024.
- Over the past year, PLSE TTM CFF has increased by +$45.62 million (+266.38%).
- PLSE TTM CFF is now -23.28% below its all-time high of $81.78 million, reached on March 31, 2021.
Performance
PLSE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PLSE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -79.5% | +10000.0% | +266.4% |
| 3 y3 years | -46.9% | +10000.0% | +0.1% |
| 5 y5 years | -64.0% | +1445.9% | +12.0% |
PLSE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -79.5% | at low | -4.9% | >+9999.0% | -21.5% | +1996.3% |
| 5 y | 5-year | -79.5% | >+9999.0% | -4.9% | >+9999.0% | -23.3% | >+9999.0% |
| alltime | all time | -79.5% | -100.0% | -4.9% | >+9999.0% | -23.3% | >+9999.0% |
Pulse Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $61.90 M(<-9900.0%) | $62.74 M(+1996.3%) |
| Jun 2024 | - | -$265.00 K(-186.9%) | $2.99 M(-82.5%) |
| Mar 2024 | - | $305.00 K(-62.1%) | $17.13 M(+4.5%) |
| Dec 2023 | $16.39 M(-79.5%) | $804.00 K(-62.6%) | $16.39 M(+5.3%) |
| Sep 2023 | - | $2.15 M(-84.5%) | $15.57 M(-80.2%) |
| Jun 2023 | - | $13.87 M(-3310.0%) | $78.48 M(-1.4%) |
| Mar 2023 | - | -$432.00 K(+2441.2%) | $79.57 M(-0.5%) |
| Dec 2022 | $79.94 M(+27.5%) | -$17.00 K(-100.0%) | $79.94 M(+0.7%) |
| Sep 2022 | - | $65.06 M(+334.8%) | $79.41 M(+254.2%) |
| Jun 2022 | - | $14.96 M(<-9900.0%) | $22.42 M(+95.6%) |
| Mar 2022 | - | -$65.00 K(-88.2%) | $11.46 M(-81.7%) |
| Dec 2021 | $62.69 M(+103.0%) | -$549.00 K(-106.8%) | $62.69 M(-1.5%) |
| Sep 2021 | - | $8.07 M(+101.6%) | $63.67 M(+13.6%) |
| Jun 2021 | - | $4.00 M(-92.2%) | $56.02 M(-31.5%) |
| Mar 2021 | - | $51.16 M(>+9900.0%) | $81.78 M(+164.8%) |
| Dec 2020 | $30.89 M | $436.00 K(+2.3%) | $30.89 M(+1.4%) |
| Sep 2020 | - | $426.00 K(-98.6%) | $30.45 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $29.76 M(>+9900.0%) | $30.22 M(<-9900.0%) |
| Mar 2020 | - | $264.00 K(>+9900.0%) | -$148.00 K(-280.5%) |
| Dec 2019 | $82.00 K(-99.8%) | $0.00(-100.0%) | $82.00 K(-99.8%) |
| Sep 2019 | - | $201.00 K(-132.8%) | $44.94 M(-0.4%) |
| Jun 2019 | - | -$613.00 K(-224.1%) | $45.14 M(-1.2%) |
| Mar 2019 | - | $494.00 K(-98.9%) | $45.69 M(+0.4%) |
| Dec 2018 | $45.50 M(+28.6%) | $44.86 M(>+9900.0%) | $45.50 M(+5428.1%) |
| Sep 2018 | - | $398.00 K(-731.7%) | $823.00 K(-97.3%) |
| Jun 2018 | - | -$63.00 K(-121.0%) | $30.43 M(-0.9%) |
| Mar 2018 | - | $300.00 K(+59.6%) | $30.71 M(-13.2%) |
| Dec 2017 | $35.38 M(+69.2%) | $188.00 K(-99.4%) | $35.38 M(+0.5%) |
| Sep 2017 | - | $30.01 M(>+9900.0%) | $35.19 M(+578.6%) |
| Jun 2017 | - | $215.00 K(-95.7%) | $5.19 M(-80.0%) |
| Mar 2017 | - | $4.97 M(>+9900.0%) | $25.89 M(+23.8%) |
| Dec 2016 | $20.91 M(>+9900.0%) | $0.00(0.0%) | $20.91 M(0.0%) |
| Sep 2016 | - | $0.00(-100.0%) | $20.91 M(0.0%) |
| Jun 2016 | - | $20.91 M | $20.91 M |
| Dec 2015 | $0.00 | - | - |
FAQ
- What is Pulse Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Pulse Biosciences?
- What is Pulse Biosciences annual CFF year-on-year change?
- What is Pulse Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pulse Biosciences?
- What is Pulse Biosciences quarterly CFF year-on-year change?
- What is Pulse Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pulse Biosciences?
- What is Pulse Biosciences TTM CFF year-on-year change?
What is Pulse Biosciences annual cash flow from financing activities?
The current annual CFF of PLSE is $16.39 M
What is the all time high annual CFF for Pulse Biosciences?
Pulse Biosciences all-time high annual cash flow from financing activities is $79.94 M
What is Pulse Biosciences annual CFF year-on-year change?
Over the past year, PLSE annual cash flow from financing activities has changed by -$63.55 M (-79.50%)
What is Pulse Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of PLSE is $61.90 M
What is the all time high quarterly CFF for Pulse Biosciences?
Pulse Biosciences all-time high quarterly cash flow from financing activities is $65.06 M
What is Pulse Biosciences quarterly CFF year-on-year change?
Over the past year, PLSE quarterly cash flow from financing activities has changed by +$61.59 M (+20194.75%)
What is Pulse Biosciences TTM cash flow from financing activities?
The current TTM CFF of PLSE is $62.74 M
What is the all time high TTM CFF for Pulse Biosciences?
Pulse Biosciences all-time high TTM cash flow from financing activities is $81.78 M
What is Pulse Biosciences TTM CFF year-on-year change?
Over the past year, PLSE TTM cash flow from financing activities has changed by +$45.62 M (+266.38%)